Olumiant 4 mg uses in the following:

• Rheumatoid arthritis treatment

• Autoimmune condition management

• Combination therapy for rheumatoid arthritis

• Investigational use in COVID-19

• Immunosuppressive effects

Olumiant 4mg tablet is a Janus kinase (JAK) inhibitor, targeting JAK1 and JAK2 enzymes. These enzymes are integral to intracellular signaling pathways involved in immune responses and inflammation. By inhibiting JAK1 and JAK2, it interferes with transmitting signals that contribute to the activation of immune cells and the production of inflammatory molecules. This modulation of signaling pathways leads to a dampened immune response and reduced inflammation, effectively managing autoimmune conditions like rheumatoid arthritis.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Olumiant 4mg tablet, reducing effectiveness by causing undesirable side effects. 

• Store at room temperature, between up to 20°C -25°C
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Olumiant 4mg tablet is typically administered orally, which means it is taken by mouth as tablets. It is available as an oral tablet for easy ingestion. Your healthcare provider will determine the specific dosage and frequency of administration based on your medical condition and individual needs. 

Olumiant 4mg side effects, like all medications, may occur in some people, although not everyone will experience them. olumiant side effects are 

Serious

• Serious infections

• Blood clots

• Malignancies

• Gastrointestinal perforations

• Liver abnormalities

Common

• Upper respiratory tract infections

• Headache

• Increased liver enzymes

• High blood pressure

• Changes in blood cell counts

• Elevated cholesterol levels

• Discuss heart health first: talk with your healthcare provider about your cardiovascular history before starting Olumiant 4mg tablet.

• Monitor blood sugar: check glucose levels regularly and contact your provider if diabetes management needs adjustment.

• Be aware of GI risks: report any severe abdominal pain or signs of gastrointestinal perforation; note history of diverticulitis or other bowel disease.

• Watch liver function: have liver enzymes checked before and during treatment; report symptoms like jaundice, dark urine, or persistent nausea.

• Check cholesterol & blood pressure: monitor lipid profile and blood pressure periodically while on treatment.

• Screen for hepatitis B: test for hepatitis B before starting therapy and manage according to local guidelines.

1. Eli Lilly and Company Limited, US Food and Drug Administration, [Revised on  5/2022] [Accessed on 29th Aug 2023], /https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s006lbl.pdf

2. Eli Lilly and Company Limited, Electronic Medicines Compendium (EMC), [Revised on 23rd Mar 2023] [Accessed on 29th Aug 2023], https://www.medicines.org.uk/emc/product/909/smpc#gref